Kiniksa Pharmaceuticals Statistics
Total Valuation
KNSA has a market cap or net worth of $1.86 billion. The enterprise value is $1.65 billion.
| Market Cap | 1.86B |
| Enterprise Value | 1.65B |
Important Dates
The last earnings date was Tuesday, July 23, 2024, before market open.
| Earnings Date | Jul 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
KNSA has 71.08 million shares outstanding. The number of shares has decreased by -0.88% in one year.
| Shares Outstanding | 71.08M |
| Shares Change (YoY) | -0.88% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 4.28% |
| Owned by Institutions (%) | 98.89% |
| Float | 14.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 409.73 |
| PS Ratio | 5.48 |
| Forward PS | 4.16 |
| PB Ratio | 4.27 |
| P/FCF Ratio | 61.21 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 54.37 |
Financial Position
The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.57 |
| Quick Ratio | 2.84 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.38 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.40% and return on invested capital (ROIC) is -6.16%.
| Return on Equity (ROE) | -2.40% |
| Return on Assets (ROA) | -2.00% |
| Return on Capital (ROIC) | -6.16% |
| Revenue Per Employee | $1.14M |
| Profits Per Employee | -$34,444 |
| Employee Count | 297 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.41 |
Taxes
| Income Tax | -7.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.31% in the last 52 weeks. The beta is 0.38, so KNSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +29.31% |
| 50-Day Moving Average | 20.04 |
| 200-Day Moving Average | 18.60 |
| Relative Strength Index (RSI) | 74.63 |
| Average Volume (20 Days) | 704,593 |
Short Selling Information
The latest short interest is 3.94 million, so 5.55% of the outstanding shares have been sold short.
| Short Interest | 3.94M |
| Short Previous Month | 4.56M |
| Short % of Shares Out | 5.55% |
| Short % of Float | 27.84% |
| Short Ratio (days to cover) | 7.39 |
Income Statement
In the last 12 months, KNSA had revenue of $338.93 million and -$10.23 million in losses. Loss per share was -$0.15.
| Revenue | 338.93M |
| Gross Profit | 297.35M |
| Operating Income | -27.51M |
| Pretax Income | -18.02M |
| Net Income | -10.23M |
| EBITDA | -12.92M |
| EBIT | -18.02M |
| Loss Per Share | -$0.15 |
Balance Sheet
The company has $218.76 million in cash and $11.40 million in debt, giving a net cash position of $207.36 million or $2.92 per share.
| Cash & Cash Equivalents | 218.76M |
| Total Debt | 11.40M |
| Net Cash | 207.36M |
| Net Cash Per Share | $2.92 |
| Equity (Book Value) | 435.10M |
| Book Value Per Share | 6.12 |
| Working Capital | 216.73M |
Cash Flow
In the last 12 months, operating cash flow was $30.47 million and capital expenditures -$131,000, giving a free cash flow of $30.34 million.
| Operating Cash Flow | 30.47M |
| Capital Expenditures | -131,000 |
| Free Cash Flow | 30.34M |
| FCF Per Share | $0.43 |
Margins
Gross margin is 87.73%, with operating and profit margins of -8.12% and -3.02%.
| Gross Margin | 87.73% |
| Operating Margin | -8.12% |
| Pretax Margin | -5.32% |
| Profit Margin | -3.02% |
| EBITDA Margin | -3.81% |
| EBIT Margin | -5.32% |
| FCF Margin | 8.95% |
Dividends & Yields
KNSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.88% |
| Shareholder Yield | 0.88% |
| Earnings Yield | -0.55% |
| FCF Yield | 1.63% |
Analyst Forecast
The average price target for KNSA is $32.00, which is 22.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.00 |
| Price Target Difference | 22.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 22.67% |
| EPS Growth Forecast (5Y) | 34.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Jun 28, 2024 |
| Split Type | n/a |
| Split Ratio | 1:1 |
Scores
KNSA has an Altman Z-Score of 10.08 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.08 |
| Piotroski F-Score | 4 |